Altona Diagnostics said on Thursday that it has received CE-IVD marking for and has launched its AltoStar HIV RT-PCR Kit 1.5.
The Hamburg, Germany-based firm’s assay leverages reverse transcriptase quantitative PCR to allow users to amplify two separate regions of the HIV-1 genome to monitor viral load in HIV-infected patients.
The new kit contains master reagents, a no-template control, and quantification standards.
“With this CE-IVD [RT-qPCR] test for the monitoring of HIV-1 for use with the AltoStar workflow, we complete our AltoStar blood-borne virus product portfolio,” Markus Hess, general manager of Altona Diagnostics, said in a statement. “The broad AltoStar assay menu now includes test systems for reliable viral load monitoring of blood-borne viruses like HIV, hepatitis B, and hepatitis C virus.”
Last April, Altona received Emergency Use Authorization from the US Food and Drug Administration and the CE-IVD mark for its PCR-based SARS-CoV-2 test kit.